A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors

Biomedicine and Pharmacotherapy

Volumn 63, Issue 8, 2009, Pages 603-607

  Zhang, Qian ^a   Huang, Xin En ^a   Gao, Li Li ^a  

^a JIANGSU CANCER HOSPITAL   (China)

Author keywords

Lipusu; Premedication; Solid tumor

Indexed keywords

ANTHRACYCLINE; CIMETIDINE; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUOROURACIL; GRANISETRON; LIPOSOME; LIPUSU; METHYLPREDNISOLONE; PACLITAXEL; PROMETHAZINE; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BREAST CANCER; CHINA; CONTROLLED STUDY; DIARRHEA; DRUG FATALITY; DRUG HYPERSENSITIVITY; DYSPHORIA; ESOPHAGUS CANCER; FATIGUE; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPERGLYCEMIA; INSOMNIA; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; PRIORITY JOURNAL; REPEATED DRUG DOSE; SIDE EFFECT; STOMACH CANCER; THROMBOCYTOPENIA; VERTIGO;

ADMINISTRATION, ORAL; ADULT; AGED; ANTHRACYCLINES; ANTIEMETICS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; GLUCOCORTICOIDS; GRANISETRON; HUMANS; INFUSIONS, INTRAVENOUS; LIPOSOMES; MALE; METHYLPREDNISOLONE; MIDDLE AGED; NEOPLASMS; PACLITAXEL; PREMEDICATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349349136     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.10.001     Document Type: Article

References (25)

1. Belotti D., Vergani V., Drudis T., Borsotti P., Pitelli M.R., Viale G., et al. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 2 (1996) 1843-1849
2. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., and Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51 (1999) 691-743
3. Van Zuylen L., Karlsson M.O., Verweij J., Brouwer E., de Bruijn P., Nooter K., et al. Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles. Cancer Chemother Pharmacol 47 (2001) 309-318
4. Szebeni J., Muggia F.M., and Alving C.R. Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. J Natl Cancer Inst 90 (1998) 300-306
5. Bookman M.A., Kloth D.D., Kover P.E., Smolinski S., and Ozols R.F. Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions. Ann Oncol 8 (1997) 611-614
6. Kobayashi M., Tsuburaya A., Nagata N., Miyashita Y., Oba K., and Sakamoto J. A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer. Gastric Cancer 9 (2006) 114-119
7. Sharma D., Chelvi T.P., Kaur J., Chakravorty K., De T.K., Maitra A., et al. Novel taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated taxol for drug delivery in cancer therapy. Oncol Res 8 (1996) 281-286
8. Scialli A.R., Waterhouse T.B., Desesso J.M., Rahman A., and Goeringer G.C. Protective effect of liposome encapsulation on paclitaxel developmental toxicity in the rat. Teratology 56 (1997) 305-310
9. Sharma A., and Straubinger R.M. Novel taxol formulations: preparation and characterization of taxol-containing liposomes. Pharm Res 11 (1994) 889-896
10. Treat J., Damjanov N., Huang C., Zrada S., and Rahman A. Liposomal-encapsulated chemotherapy: preliminary results of a phase I study of a novel liposomal paclitaxel. Oncology (Williston Park) 15 (2001) 44-48
11. Yang A., Li J., Xu H., and Chen H. A study on antitumor effect of liposome encapsulated paclitaxel in vivo and in vitro. Bull Chin Cancer 15 (2006) 862-864 (in Chinese)
12. Kong F., Dong Q., and Cao X. Effect of paclitaxel combined with cisplatin in treatment of non small cell lung cancer. Pract J Cancer 22 (2007) 513-514 (in Chinese)
13. Chen Q., Zhang Q., Liu J., Li L., Zhao W., Wang Y., et al. Multi-center prospective randomized trial on paclitaxel liposome and traditional taxol in the treatment of breast cancer and non-small-cell lung cancer. Chin J Oncol 25 (2003) 190-192 (in Chinese)
14. Common Terminology Criteria for Adverse Events v3.0 (CTCAE), available at: [accessed August 12, 2008].
15. Kosmas C., and Tsavaris N. A simplified premedication protocol for one-hour paclitaxel infusion in various combinations. Med Sci Monit 12 (2006) 462-466
16. Bonomi P., Kim K., Fairclough D., Cella D., Kugler J., Rowinsky E., et al. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. J Clin Oncol 18 (2000) 623-631
17. Micha J.P., Rettenmaier M.A., Dillman R., Fraster P., Birk C., and Brown J.V. Single-dose dexamethasone paclitaxel premedication. Gynecol Oncol 69 (1998) 122-124
18. Straubinger R.M., Sharma A., Murray M., and Mayhew E. Novel taxol formulations: taxol-containing liposomes. J Natl Cancer Inst Monogr 15 (1993) 69-78
19. Sharma A., Mayhew E., and Straubinger R.M. Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. Cancer Res 53 (1993) 5877-5881
20. Cabanes A., Briggs K.E., Gokhale P.C., Treat J.A., and Rahman A. Comparative in vivo studies with paclitaxel and liposome encapsulated paclitaxel. Int J Oncol 12 (1998) 1035-1040
21. Schmitt-Sody M., Strieth S., Krasnici S., Sauer B., Schulze B., Teifel M., et al. Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy. Clin Cancer Res 9 (2003) 2335-2341
22. Zhou W., Weng G., Chen W., Zhuang Y., Fu X., and Cheng G. Tissue distribution of paclitaxel liposome in rats. J Chin Pharm 40 (2005) 1402-1404 (in Chinese)
23. Wu H., Zhao Y., and Liu T. Effects of paclitaxel liposomal and traditional paclitaxel in the treatment of advanced breast cancer. Central Plains Med J 34 (2007) 20-22 (in Chinese)
24. Lin J., Luo Y., and Shi C. An analysis of paclitaxel liposome in treatment for 54 cases with advanced non-small-cell lung cancer. Bull Chin Cancer 17 (2008) 326-327 (in Chinese)
25. Liu B. Clinical application of new dosage form of paclitaxel - paclitaxel liposome. Eval Anal Drug Use Hosp China 7 (2007) 59-60 (in Chinese)